Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,192 | -24,208 | -18,730 | -8,874 | -951 |
| Other Working Capital | -1,168 | 5,482 | 2,732 | 3,300 | 960 |
| Other Operating Activity | -247 | 839 | 1,406 | -2,304 | -3,446 |
| Operating Cash Flow | $-3,607 | $-17,887 | $-14,592 | $-7,878 | $-3,437 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 5 | 5 | 5 | 5 |
| Investing Cash Flow | $N/A | $5 | $5 | $5 | $5 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7,534 | 7,534 | N/A | N/A |
| Debt Repayment | -415 | -1,408 | -266 | -266 | N/A |
| Common Stock Issued | 2,689 | 3,783 | N/A | N/A | N/A |
| Other Financing Activity | -399 | -1,143 | -442 | -391 | -391 |
| Financing Cash Flow | $1,875 | $8,766 | $6,826 | $-657 | $-391 |
| Beginning Cash Position | 3,148 | 12,265 | 12,265 | 12,265 | 12,265 |
| End Cash Position | 1,416 | 3,148 | 4,503 | 3,735 | 8,441 |
| Net Cash Flow | $-1,732 | $-9,117 | $-7,762 | $-8,530 | $-3,824 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,607 | -17,887 | -14,592 | -7,878 | -3,437 |
| Free Cash Flow | -3,607 | -17,887 | -14,592 | -7,878 | -3,437 |